Which of the following is a stage in the life of an organization?
A. Birth
B. Decline
C. Elderly
D. Introduction
E. Growth
A. Birth
The four-stage organizational life cycle has a natural sequence of stages: birth, youth, midlife, and maturity.
You might also like to view...
Which of the following would not be classified as a separately stated item?
A. Charitable contributions. B. MACRS depreciation expense. C. Guaranteed payments. D. Short-term capital gains.
Under a ______ the employee does not know what their retirement benefit will be.
A. utilization analysis B. defined contribution plan C. vesting plan D. defined benefit plan
Uncommitted inventory that is physically on-hand is called ______.
a. ready-to-buy b. ready-to-sell c. made-to-stock d. available-to-promise
Norris Production Company (NPC) is considering a project that has an up-front cost at t = 0 of $2,400. (All dollars in this problem are in thousands.) The project's subsequent cash flows are critically dependent on whether a competitor's product is approved by the Food and Drug Administration. If the FDA rejects the competitive product, NPC's product will have high sales and cash flows, but if the competitive product is approved, that will negatively impact NPC. There is a 50% chance that the competitive product will be rejected, in which case NPC's expected cash flows will be $700 at the end of each of the next seven years (t = 1 to 7). There is a 50% chance that the competitor's product will be approved, in which case the expected cash flows will be only $50 at the end of each of the
next seven years (t = 1 to 7). NPC will know for sure one year from today whether the competitor's product has been approved. ? NPC is considering whether to make the investment today or to wait a year to find out about the FDA's decision. If it waits a year, the project's up-front cost at t = 1 will remain at $2,400, the subsequent cash flows will remain at $700 per year if the competitor's product is rejected and $50 per year if the alternative product is approved. However, if NPC decides to wait, the subsequent cash flows will be received only for six years (t = 2 ... 7). In addition, once NPC knows the outcome of the FDA's decision, it will not take on the project if its NPV is negative. ? This is a risky project, so a WACC of 16.0% is to be used. If NPC chooses to wait a year before proceeding, what is the value (in thousand) of the timing option today? Do not round intermediate calculations. ? A. $88.88 B. $92.75 C. $73.43 D. $77.29 E. $57.97